Occurrence of qnrA -positive clinical isolates in French teaching hospitals during 2002-2005

Clinical Microbiology and Infection

Volumn 12, Issue 10, 2006, Pages 1013-1020

  Cambau, Emmanuelle ^a   Lascols, C ^a   Sougakoff, W ^b   Bebear C ^c   Bonnet, R ^d   Cavallo, J D ^e   Gutmann, L ^f   Ploy, M C ^g   Jarlier, V ^b   Soussy, C J ^a   Robert, J ^b  

^a UNIVERSITÉ PARIS EST CRÉTEIL   (France)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^c HÔPITAL PELLEGRIN   (France)

^d SERVICE DE RHUMATOLOGIE   (France)

^e SERVICE D ENDOCRINOLOGIE   (France)

^f HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^g DUPUYTREN UNIVERSITY HOSPITAL   (France)

Author keywords

Enterobacteriaceae; Extended spectrum lactamase; France; Integron; qnrA; Quinolone resistance

Indexed keywords

AMIKACIN; BACTERIAL DNA; BACTERIAL PROTEIN; CEFEPIME; CEFOTAXIME; CEFTAZIDIME; CEFTRIAXONE; CHLORAMPHENICOL; CIPROFLOXACIN; EXTENDED SPECTRUM BETA LACTAMASE; GENTAMICIN; IMIPENEM; LEVOFLOXACIN; MOXIFLOXACIN; NALIDIXIC ACID; NETILMICIN; OFLOXACIN; PIPERACILLIN; PROTEIN QNRA; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SULFONAMIDE; TETRACYCLINE; TRIMETHOPRIM; UNCLASSIFIED DRUG;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; CITROBACTER FREUNDII; CONTROLLED STUDY; ENTEROBACTER CLOACAE; ENTEROBACTERIACEAE; FRANCE; FREQUENCY ANALYSIS; GENETIC VARIABILITY; INTEGRON; KLEBSIELLA OXYTOCA; KLEBSIELLA PNEUMONIAE; MINIMUM INHIBITORY CONCENTRATION; MOLECULAR CLONING; MOLECULAR TYPING; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPIC VARIATION; PLASMID; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; PROTEUS MIRABILIS; TEACHING HOSPITAL;

CITROBACTER FREUNDII; ENTEROBACTER CLOACAE; ENTEROBACTERIACEAE; KLEBSIELLA OXYTOCA; KLEBSIELLA PNEUMONIAE; PROTEUS MIRABILIS;

EID: 33748313046     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2006.01529.x     Document Type: Article

References (41)

1. Martinez-Martinez L, Pascual A, Jacoby GA. Quinolone resistance from a transferable plasmid. Lancet 1998; 351: 797-799.
2. Tran JH, Jacoby GA. Mechanism of plasmid-mediated quinolone resistance. Proc Natl Acad Sci USA 2002; 99: 5638-5642.
3. Hooper DC. Bacterial topoisomerases, anti-topoisomerases, and anti-topoisomerase resistance. Clin Infect Dis 1998; 27 (suppl): 54-63.
4. Hooper DC. Mechanisms of quinolone resistance. In: Hooper DC, Rubinstein E, eds, Quinolone antimicrobial agents, 3rd edn. Washington, DC: ASM Press, 2003; 41-67.
5. Hata M, Suzuki M, Matsumoto M et al. Cloning of a novel gene for quinolone resistance from a transferable plasmid in Shigella flexneri 2b. Antimicrob Agents Chemother 2005; 49: 801-803.
6. Jacoby GA, Walsh KE, Mills DM et al. qnrB, another plasmid-mediated gene for quinolone resistance. Antimicrob Agents Chemother 2006; 50: 1178-1182.
7. Nordmann P, Poirel L. Emergence of plasmid-mediated resistance to quinolones in Enterobacteriaceae. J Antimicrob Chemother 2005; 56: 463-469.
8. Vetting MW, Hegde SS, Fajardo JE et al. Pentapeptide repeat proteins. Biochemistry 2006; 45: 1-10.
9. Engelberg-Kulka H, Glaser G. Addiction modules and programmed cell death and antideath in bacterial cultures. Annu Rev Microbiol 1999; 53: 43-70.
10. Montero C, Mateu G, Rodriguez R, Takiff H. Intrinsic resistance of Mycobacterium smegmatis to fluoroquinolones may be influenced by new pentapeptide protein MfpA. Antimicrob Agents Chemother 2001; 45: 3387-3392.
11. Wang M, Tran JH, Jacoby GA, Zhang Y, Wang F, Hooper DC. Plasmid-mediated quinolone resistance in clinical isolates of Escherichia coli from Shanghai, China. Antimicrob Agents Chemother 2003; 47: 2242-2248.
12. Wang M, Sahm DF, Jacoby GA, Hooper DC. Emerging plasmid-mediated quinolone resistance associated with the qnr gene in Klebsiella pneumoniae clinical isolates in the United States. Antimicrob Agents Chemother 2004; 48: 1295-1299.
13. Mammeri H, Van De Loo M, Poirel L, Martinez-Martinez L, Nordmann P. Emergence of plasmid-mediated quinolone resistance in Escherichia coli in Europe. Antimicrob Agents Chemother 2005; 49: 71-76.
14. Jacoby GA, Chow N, Waites KB. Prevalence of plasmid-mediated quinolone resistance. Antimicrob Agents Chemother 2003; 47: 559-562.
15. Rodriguez-Martinez JM, Pascual A, Garcia I, Martinez-Martinez L. Detection of the plasmid-mediated quinolone resistance determinant qnr among clinical isolates of Klebsiella pneumoniae producing AmpC-type β-lactamase. J Antimicrob Chemother 2003; 52: 703-729.
16. Robicsek A, Sahm DF, Strahilevitz J, Jacoby GA, Hooper DC. Broader distribution of plasmid-mediated quinolone resistance in the United States. Antimicrob Agents Chemother 2005; 49: 3001-3003.
17. Poirel L, Van de Loo M, Mammeri H, Nordmann P. Association of plasmid-mediated quinolone resistance with extended-spectrum β-lactamase VEB-1. Antimicrob Agents Chemother 2005; 49: 3091-3094.
18. Jeong JY, Yoon HJ, Kim ES et al. Detection of qnr in clinical isolates of Escherichia coli from Korea. Antimicrob Agents Chemother 2005; 49: 2522-2524.
19. Cheung TK, Chu YW, Chu MY, Ma CH, Yung RW, Kam KM. Plasmid-mediated resistance to ciprofloxacin and cefotaxime in clinical isolates of Salmonella enterica serotype Enteritidis in Hong Kong. J Antimicrob Chemother 2005; 56: 586-589.
20. Jonas D, Biehler K, Hartung D, Spitzmuller B, Daschner FD. Plasmid-mediated quinolone resistance in isolates obtained in German intensive care units. Antimicrob Agents Chemother 2005; 49: 773-775.
21. Corkill JE, Anson JJ, Hart A. High prevalence of the plasmid-mediated quinolone resistance determinant qnrA in multidrug-resistant Enterobacteriacae from blood cultures in Liverpool, UK. J Antimicrob Chemother 2005; 56: 1115-1117.
22. Cornaglia G, Hryniewicz W, Jarlier V et al. European recommendations for antimicrobial resistance surveillance. Clin Microbiol Infect 2004; 10: 349-383.
23. Anonymous. Comitéde l'Antibiogramme de la SociétéFrancaise de Microbiologie report 2003. Int J Antimicrob Agents 2003; 21: 364-391.
24. Jarlier V, Nicolas MH, Fournier G, Philippon A. Extended broad-spectrum beta-lactamases conferring transferable resistance to newer β-lactam agents in Enterobacteriaceae: Hospital prevalence and susceptibility patterns. Rev Infect Dis 1988; 10: 867-878.
25. Bradford PA. Extended-spectrum β-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat. Clin Microbiol Rev 2001; 14: 933-951.
26. Paterson DL, Bonomo RA. Extended spectrum β-lactamases: A clinical update. Clin Microbiol Rev 2005; 18: 657-686.
27. Alvarez M, Tran JH, Chow N, Jacoby GA. Epidemiology of conjugative plasmid-mediated AmpC β-lactamases in the United States. Antimicrob Agents Chemother 2004; 48: 533-537.
28. Naas T, Benaoudia F, Massuard S, Nordmann P. Integron-located VEB-1 extended spectrum beta-lactamase gene in Proteus mirabilis clinical isolate from Vietnam. J Antimicrob Chemother 2000; 46: 703-711.
29. Chabbert YA, Derlot E. Comparative activity of cefotetan on Escherichia coli K-12 possessing plasmid-mediated β-lactamases. J Antimicrob Chemother 1983; 11 (suppl): 159-167.
30. Versalovic J, Koeuth T, Lupski JR. Distribution of repetitive DNA sequences in eubacteria and application to fingerprinting of bacterial genomes. Nucleic Acids Res 1991; 19: 682-687.
31. Gori A, Espinasse F, Deplano A, Nonhoff C, Nicolas MH, Struelens MJ. Comparison of pulse-field gel electrophoresis and randomly amplified DNA polymorphism analysis for typing extended-spectrum-β-lactamase-producing Klebsiella pneumoniae. J Clin Microbiol 1996; 34: 2448-2453.
32. Tenover FC, Arbeit RD, Goering RV et al. How to select and interpret molecular strain typing methods for epidemiological studies of bacterial infections: A review for healthcare epidemiologists. Infect Control Hosp Epidemiol 1997; 18: 426-437.
33. Nijssen S, Florijn A, Top J, Willems R, Fluit A, Bonten M. Unnoticed spread of integron-carrying Enterobacteriaceae in intensive care units. Clin Infect Dis 2005; 41: 1-9.
34. Machado E, Canton R, Baquero F et al. Integron content of extended-spectrum-beta-lactamase-producing Escherichia coli strains over 12 years in a single hospital in Madrid, Spain. Antimicrob Agents Chemother 2005; 49: 1823-1829.
35. Nuesch-Inderbinen MT, Kayser FH, Hachler H. Survey and molecular genetics of SHV beta-lactamases in Enterobacteriaceae in Switzerland: two novel enzymes, SHV-11 and SHV-12. Antimicrob Agents Chemother 1997; 41: 943-949.
36. Nazic H, Poirel L, Nordmann P. Further identification of plasmid-mediated quinolone resistance determinant in Enterobacteriaceae in Turkey. Antimicrob Agents Chemother 2005; 49: 2146-2147.
37. Branger C, Zamfir O, Geoffroy S et al. Genetic background of Escherichia coli and extended-spectrum beta-lactamase type. Emerg Infect Dis 2005; 11: 54-61.
38. Verdet C, Arlet G, Barnaud G, Lagrange PH, Philippon A. A novel integron in Salmonella enterica serovar Enteritidis, carrying the bla (DHA-1) gene and its regulator gene ampR, originated from Morganella morganii. Antimicrob Agents Chemother 2000; 44: 222-225.
39. Martinez-Martinez L, Pascual A, Garcia I, Tran J, Jacoby GA. Interaction of plasmid and host quinolone resistance. J Antimicrob Chemother 2003; 51: 1037-1039.
40. Wang M, Sahm DF, Jacoby GA, Zhang Y, Hooper DC. Activities of newer quinolones against Escherichia coli and Klebsiella pneumoniae containing the plasmid-mediated quinolone resistance determinant qnr. Antimicrob Agents Chemother 2004; 48: 1400-1401.
41. Mooij MJ, Schouten I, Vos G et al. Class 1 integrons in ciprofloxacin-resistant Escherichia coli strains from two Dutch hospitals. Clin Microbiol Infect 2005; 11: 898-902.